Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19Jerald Sadoff, Macaya Douoguih, Glenda Gray et al.|New England Journal of Medicine|2021Cited by 2.6k
Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometryPratip K. Chattopadhyay, Mario Roederer, David A. Price et al.|Nature Medicine|2006Cited by 368
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.SJerald Sadoff, Macaya Douoguih, Ilse Van Dromme et al.|New England Journal of Medicine|2022Cited by 250
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like ParticlesPaul Goepfert, Harriet L. Robinson, Marnie Elizaga et al.|The Journal of Infectious Diseases|2011Cited by 177
A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)Gavin Churchyard, Cecilia Morgan, Elizabeth M. Adams et al.|PLoS ONE|2011Cited by 137